Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index; 20 of the 65 sources its claims cite were checked for support.
Abstract
Background: To determine the efficacy of different visible light therapies in treating seasonal affective disorder (SAD) through both direct and indirect comparisons. Methods: We conducted a search of the PubMed, Embase, Cochrane Library, Scopus, Web of Science, China National Knowledge Infrastructure, Wanfang, VIP, and China Biomedical Literature databases for randomized controlled trials up to November 12, 2024. The using search terms were: white light, blue light, green light, and SAD/winter depression. Two independent researchers reviewed and extracted the data. Results: After screening, a total of 17 studies were obtained, involving 773 patients. These studies included 14 on white light, 6 on blue light, 2 on green light, and 5 on red light. The results indicated that, in terms of alleviating seasonal mood dysregulation or typical depressive symptoms, white light therapy was most effective, followed by green light, blue light and red light. Furthermore, usual care of SAD was found to be more effective than green light therapy in improving seasonal mood dysregulation. Conclusion: The existing evidence suggests that white light may be the best visible light therapy for patients with SAD, with usual care being more effective than green light. However, larger-scale studies are still needed to verify the potential differences among green light and blue light, further comprehensively evaluate the effectiveness of visible light at different wavelengths for SAD.
Overview
CoChat Summary
TL;DR
This systematic review and network meta-analysis of 17 RCTs (773 patients) found white light ranked highest for reducing seasonal affective disorder symptoms on both SIGH-SAD and HDRS, followed generally by green, blue, and red light. Usual care ranked above green light in both analyses, but evidence quality was low or very low for some comparisons and green-light estimates were imprecise.
Key findings
- Across 17 RCTs involving 773 patients, white light had the highest SUCRA for SIGH-SAD (80.7%) and HDRS (81.7%), ahead of green light (60.4% and 67.4%), blue light (46.6% and 54.6%), and red light (21.0% and 8.4%).
- Relative to placebo on SIGH-SAD, estimated effects were green light SMD = −6.92 (95% CI −35.91 to 21.78), white light SMD = −5.96 (95% CI −9.41 to −2.90), blue light SMD = −2.81 (95% CI −6.39 to 0.45), and red light SMD = −0.38 (95% CI −4.53 to 3.73).
- On HDRS, white light (SMD = −5.76, 95% CI −9.12 to −2.50), green light (SMD = −5.51, 95% CI −13.00 to 2.30), and blue light (SMD = −4.43, 95% CI −7.67 to −1.34) showed significant efficacy versus placebo, while red light was less effective than placebo (SMD = 0.99, 95% CI −3.58 to 5.41).
- Usual care ranked above green light therapy in both SIGH-SAD (SUCRA 75.5% vs 60.4%) and HDRS (SUCRA 70.9% vs 67.4%).
Methods
- Systematic review and network meta-analysis registered in PROSPERO (CRD42025637686), following PRISMA, searching PubMed, Embase, Cochrane Library, Scopus, Web of Science, CNKI, Wanfang, VIP, and China Biomedical Literature up to November 12, 2024 for RCTs in English or Chinese.
- Included 17 RCTs with 773 participants; interventions were white, blue, green, and red light, with controls including usual care, placebo, and red light.
- Primary outcome was endpoint score difference on SIGH-SAD; secondary outcome was HDRS. Analysis used R software, random-effects models, standardized mean difference with 95% CI, SUCRA rankings, global and local inconsistency tests, sensitivity analysis, and funnel plots.
Limitations
- Stated: the number of RCTs and sample sizes were limited; some studies had potential biases, including unclear randomization, allocation concealment, or blinding, and studies varied in light exposure timing, intensity, duration, and wavelength.
- Stated: direct comparisons between some visible lights were lacking; only 2 green-light studies were included and they were outdated; outcomes lacked sleep-quality indicators; and included studies were predominantly from mid-to-high-latitude regions, with scarce low-latitude data.
- Evident from the text: GRADE evidence quality was moderate for white light versus blue light, low for white light versus green light, and very low for white light versus red light, and green-light effect estimates had very wide confidence intervals, indicating imprecision.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
14 Valid · 2 Not valid · 13 Not checked · 72 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the level of evidence is often downgraded due to inaccuracies and internal biases within studies.[41]”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
What the sources say
- Supportedcites [41] Dhippayom T Saensook T Promkhatja N Teaktong T Chaiyakunapruk N Devine B. Comparative effects of music interventions on depression in older adults: a systematic review and network meta-analysis. EClinicalMedicine. 2022; 50: 101509. 35812990 PMC9257333 source
The Results (‘Effects on depression’) state that evidence levels were most often downgraded for imprecision and within-study bias. The claim paraphrases those reasons, although ‘imprecision’ is more precise than ‘inaccuracies.’ (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Fourteen articles[25–36,38,39] reported the effects of various visible light interventions on SIGH-SAD of patients with SAD.”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
What the sources say
- Not checked — no full text of the sourcecites [25] Anderson JL Glod CA Dai J Cao Y Lockley SW. Lux vs. wavelength in light treatment of seasonal affective disorder. Acta Psychiatr Scand. 2009; 120: 203– 12. 19207131 source
- Partly supportedcites [26] Anderson JL Hilaire MA Auger RR. Are short (blue) wavelengths necessary for light treatment of seasonal affective disorder? Chronobiol Int. 2016; 33: 1267– 79. 27494399 PMC5292307 sourceExperimental — accuracy not yet measured
The Methods (Study Procedures) and Results (SIGH-ADS) show that this article tested visible-light treatments in patients with SAD and reported depression-rating outcomes. It identifies the measure as SIGH-ADS, however, not SIGH-SAD; our copy does not establish that the two names refer to the same measure. The count of fourteen articles is a statement about the citing paper’s group of references, not a finding this individual source could establish. (LLM, conf=0.82)
- Not checked yetcites [27] Desan PH Weinstein AJ Michalak EE. A controlled trial of the litebook light-emitting diode (LED) light therapy device for treatment of seasonal affective disorder (SAD). BMC Psychiatry. 2007; 7: 38. 17683643 PMC1971065 source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [28] Flory R Ametepe J Bowers B. A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of seasonal affective disorder. Psychiatry Res. 2010; 177: 101– 8. 20381162 source
- Not checked yetcites [29] Gordijn MCM 't Mannetje D Meesters Y. The effects of blue-enriched light treatment compared to standard light treatment in seasonal affective disorder. J Affect Disord. 2012; 136: 72– 80. 21911257 source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [30] Magnusson A Kristbjarnarson H. Treatment of seasonal affective disorder with high-intensity light. A phototherapy study with an Icelandic group of patients. J Affect Disord. 1991; 21: 141– 7. 1827641 source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [31] Meesters Y Dekker V Schlangen LJ Bos EH Ruiter MJ. Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry. 2011; 11: 17. 21276222 PMC3042929 source
The Methods (Subjects and Assessment and procedure) describe patients with seasonal affective disorder receiving two visible-light treatments and repeated SIGH-SAD assessments. The Results (Weekly assessments) report SIGH-SAD outcomes for both treatments. This paper therefore fits as one of the articles identified by the citing sentence; the count of fourteen refers to the citing document’s group of references, not to this paper alone. (LLM, conf=0.93)
- Not checked yetcites [32] Meesters Y Duijzer WB Hommes V. The effects of low-intensity narrow-band blue-light treatment compared to bright white-light treatment in seasonal affective disorder. J Affect Disord. 2018; 232: 48– 51. 29477098 source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [33] Rohan KJ Mahon JN Evans M. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: acute outcomes. Am J Psychiatry. 2015; 172: 862– 9. 25859764 PMC7962797 source
The Methods (Abstract and Outcome Measures) describe a trial of light therapy in adults with seasonal affective disorder, with SIGH-SAD scores as an outcome. The Results (Continuous Treatment Outcomes) report changes in those scores. This paper therefore qualifies as one of the articles the citing sentence identifies; the count of fourteen refers to the citing document’s group of references. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [34] Rohan KJ Roecklein KA Tierney Lindsey K. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. J Consult Clin Psychol. 2007; 75: 489– 500. 17563165 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although there is substantial evidence showing that blue light has significant therapeutic effects on SAD,[32,38,46]”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 4. Discussion
What the sources say
- Supportedcites [32] Meesters Y Duijzer WB Hommes V. The effects of low-intensity narrow-band blue-light treatment compared to bright white-light treatment in seasonal affective disorder. J Affect Disord. 2018; 232: 48– 51. 29477098 source
The Abstract (Results/Conclusions) reports that on day 15 SIGH-SAD ratings were significantly lower than on day 1 in the narrow-band blue-light arm (67% improvement, effect size 2.63) and concludes that 'the use of narrow-band blue light is equally effective as a treatment using bright white-light'. Section 2 (Results) states 'Both therapies were found to be highly effective in reducing SIGH-SAD scores and improving energy levels', with 58.3% of BLUE subjects meeting Terman remission criteria. The Introduction additionally reviews supporting evidence (blue-enriched light superior to placebo, Desan et al. 2007; blue superior to red light, Glickman et al. 2006; Strong et al. 2009), so the source does carry the point that blue light has significant therapeutic effects in SAD; its Discussion only qualifies superiority over white light and the role of the blue spectrum, not the therapeutic effect itself. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [38] Strong RE Marchant BK Reimherr FW Williams E Soni P Mestas R. Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms. Depress Anxiety. 2009; 26: 273– 8. 19016463 source
- Could not verifycites [46] Barroggi Constantino D Lederle KA Middleton B. The bright and dark side of blue-enriched light on sleep and activity in older adults. Geroscience. 2025; 47: 3927– 39. 39821044 PMC12181448 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports improved sleep and rest-activity rhythms with morning blue-enriched light in older adults, not treatment of seasonal affective disorder (SAD). Searches for SAD, seasonal affective disorder, depression, and light treatment found no passage in our copy addressing therapeutic effects on SAD. (LLM, conf=0.76)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thirteen articles[23,28–38,40] reported the effects of different visible light interventions on HDRS of patients with SAD”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
What the sources say
- Not checked — no full text of the sourcecites [23] Lam RW Levitt AJ Levitan RD. The can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry. 2006; 163: 805– 12. 16648320 source
- Not checked — no full text of the sourcecites [28] Flory R Ametepe J Bowers B. A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of seasonal affective disorder. Psychiatry Res. 2010; 177: 101– 8. 20381162 source
- Not checked yetcites [29] Gordijn MCM 't Mannetje D Meesters Y. The effects of blue-enriched light treatment compared to standard light treatment in seasonal affective disorder. J Affect Disord. 2012; 136: 72– 80. 21911257 source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [30] Magnusson A Kristbjarnarson H. Treatment of seasonal affective disorder with high-intensity light. A phototherapy study with an Icelandic group of patients. J Affect Disord. 1991; 21: 141– 7. 1827641 source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [31] Meesters Y Dekker V Schlangen LJ Bos EH Ruiter MJ. Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry. 2011; 11: 17. 21276222 PMC3042929 source
The Methods describe a trial comparing two light treatments in patients with seasonal affective disorder. The Results (Weekly assessments; page unavailable) report Hamilton Rating Scale for Depression (HRSD) scores for both treatment groups. This paper is therefore one of the articles the citing sentence identifies; the count of thirteen is the citing authors’ count, not a finding attributed to this paper. (LLM, conf=0.92)
- Not checked yetcites [32] Meesters Y Duijzer WB Hommes V. The effects of low-intensity narrow-band blue-light treatment compared to bright white-light treatment in seasonal affective disorder. J Affect Disord. 2018; 232: 48– 51. 29477098 source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [33] Rohan KJ Mahon JN Evans M. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: acute outcomes. Am J Psychiatry. 2015; 172: 862– 9. 25859764 PMC7962797 source
This citation identifies one of the articles counted by the citing authors, rather than attributing the count of thirteen to this paper. The Methods describe a light-therapy trial in adults with seasonal affective disorder using the Hamilton-based SIGH-SAD measure; the Results report changes in SIGH-SAD scores and its HAM-D subscale. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [34] Rohan KJ Roecklein KA Tierney Lindsey K. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. J Consult Clin Psychol. 2007; 75: 489– 500. 17563165 source
- Not checked — no full text of the sourcecites [35] Stewart KT Gaddy JR Byrne B Miller S Brainard GC. Effects of green or white light for treatment of seasonal depression. Psychiatry Res. 1991; 38: 261– 70. 1754638 source
- Not checked — no full text of the sourcecites [36] Terman M Terman JS. Controlled trial of naturalistic dawn simulation and negative air ionization for seasonal affective disorder. Am J Psychiatry. 2006; 163: 2126– 33. 17151164 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| Blue light, red light | 5.5 (−2.4 to 14.0) | 1.4 (−3.2 to 6.2) | 2.4 (−1.5 to 6.6) | .36 |”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
36 more claims
Create a free account to see all 101 claims and to verify the 17 references still open.
- Probably not a substantial claim. 28
- It may state two separate claims as one. 38
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Stimulus control directly targets conditioned arousal, a key mechanism of insomnia in which the bed and bedroom environment become cues for wakefulness rather than sleep [41].”
From Pre-Sleep Anxiety: Mechanisms and Therapeutic Approaches in Clinical Practice. (2026) · cites this paper as [41]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CBT-I is the established first-line treatment for chronic insomnia and has been applied to address sleep onset anxiety [41,42].”
From Pre-Sleep Anxiety: Mechanisms and Therapeutic Approaches in Clinical Practice. (2026) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“| White light | 0.40 (−1.47 to 2.22) | 0.33 (−7.32 to 8.01) | 1.33 (−0.96 to 3.58) | 4.82 (1.26–8.34) | 5.76 (2.50–9.12) |”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“| −1.33 (−6.00 to −0.40) | −0.92 (−3.88 to 2.01) | −1.02 (−8.83 to 6.90) | Blue light | 3.47 (−0.58 to 7.53) | 4.43 (1.34–7.67) |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“Relative to the placebo group, white light (SMD = −5.76, 95%CI = [−9.12, −2.50]), green light (SMD = −5.51, 95%CI = [−13.00 to 2.30]) and blue light (SMD = −4.43, 95% CI = [−7.67 to −1.34]) had significant efficacy”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“| −4.82 (−8.34 to −1.26) | −4.42 (−8.18 to −0.68) | −4.43 (−13.08 to 3.97) | −3.47 (−7.53 to 0.58) | Placebo | 0.99 (−3.58 to 5.41) | | −5.76 (−9.12 to −2.50) | −5.36 (−9.21 to −1.63) | −5.51 (−13.00 to 2.30) | −4.43 (−7.67 to −1.34) | −0.99 (−5.41 to 3.58) | Red light |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“green light (SMD = −5.51, 95%CI = [−13.00 to 2.30]) and blue light (SMD = −4.43, 95% CI = [−7.67 to −1.34]) had significant efficacy”
§ Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis > 3. Results > 3.4. Network meta-analysis
“| −5.76 (−9.12 to −2.50) | −5.36 (−9.21 to −1.63) | −5.51 (−13.00 to 2.30) | −4.43 (−7.67 to −1.34) | −0.99 (−5.41 to 3.58) | Red light |”
Citations
Cites
Golden, R. N., Gaynes, B. N., Ekstrom, R. D., Hamer, R. M., Jacobsen, F. M., Suppes, T., Wisner, K. L., & Nemeroff, C. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.656 · Cited by 896
Network meta-analysis: an introduction for clinicians
Rouse, B., Chaimani, A., & Li, T. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1583-7 · Cited by 875 · cited 1×
“[24] Additionally, to select an appropriate model to describe the variability of the data, we implemented both global and local inconsistency tests.”
Bright Light Treatment of Winter Depression: A Placebo-Controlled Trial
Eastman, C. I., Young, M. A., Fogg, L. F., Liu, L., & Meaden, P. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.10.883 · Cited by 347 · cited 1×
“[22,23] Therefore, we had adopted the endpoint score difference in Hamilton Scale scores as a secondary indicator in this study.”
Spectral quality of light modulates emotional brain responses in humans.
Vandewalle, G., Schwartz, S., Grandjean, D., Wuillaume, C., Balteau, E., Degueldre, C., Schabus, M., Phillips, C., Luxen, A., Dijk, D. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010180107 · Cited by 255 · cited 1×
“[13] Since the intrinsically photosensitive retinal ganglion cells (ipRGCs) are more sensitive to blue light wavelengths, the melatonin-suppressing effect of blue light at lower intensities is even stronger than that of brighter white light, [14] in this regard, blue light has shown a more…”
Lam, R. W., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R., Michalak, E. E., & Tam, E. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.805 · Cited by 232 · cited 4×
“[22,23] Therefore, we had adopted the endpoint score difference in Hamilton Scale scores as a secondary indicator in this study.”
InfluentialAn, K., Zhao, H., Miao, Y., Xu, Q., Li, Y.-F., Ma, Y.-Q., Shi, Y.-M., Shen, J.-W., Meng, J.-J., Yao, Y.-G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0640-8 · Cited by 176 · cited 1×
“[15] 16–18] While green light may have effects similar to those of white light, such as inhibiting melatonin, altering circadian rhythms, and improving depression, it may be more effective.”
Seasonal Affective Disorder: An Overview of Assessment and Treatment Approaches
Melrose, S. (2015) · Depression Research and Treatment · doi:10.1155/2015/178564 · Cited by 168
Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., & Winkler, D. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000502891 · Cited by 136 · cited 1×
“The prior research has proven the validity of phototherapy in alleviating symptoms of SAD, [11] has conducted the comparative analysis of the efficacy between light therapy and primary treatment (antipsychotic drugs, psychological treatments, etc).”
Long-lasting antinociceptive effects of green light in acute and chronic pain in rats.
Ibrahim, M. M., Patwardhan, A., Gilbraith, K. B., Moutal, A., Yang, X., Chew, L. A., Largent-Milnes, T., Malan, T. P., Vanderah, T. W., Porreca, F., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000767 · Cited by 123 · cited 1×
“[44,45] Based on our study findings, the efficacy of conventional rehabilitation treatments excluding light therapy, is superior to that of green light therapy.”
Exposure to light at night and risk of depression in the elderly.
Obayashi, K., Saeki, K., Iwamoto, J., Ikada, Y., & Kurumatani, N. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.018 · Cited by 117 · cited 1×
“[15] 16–18] While green light may have effects similar to those of white light, such as inhibiting melatonin, altering circadian rhythms, and improving depression, it may be more effective.”
Cited by
Seasonal affective disorder: More than the winter blues
Colombo, K. D. (2025) · Nursing Made Incredibly Easy! · doi:10.1097/nme.0000000000000127 · Cited by 1
Li, J., Chen, P., Chen, G., Guo, Z., Yang, Z., Sun, S., Qi, Z., Huang, L., Ma, W., Zhang, Y., et al. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01170 · Cited by 1
Mascherek, A., Diedrichsen, L., Mostajeran, F., & Kühn, S. (2026) · Environmental Research · doi:10.1016/j.envres.2026.125745
Pre-Sleep Anxiety: Mechanisms and Therapeutic Approaches in Clinical Practice.
Song, S., Irfan, M., Tahir, Z., Garrison, K. A., & Ziskind, S. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00370-2
Polu, P. R. (2026) · Biological Rhythm Research · doi:10.1080/09291016.2025.2612550
Metadata
- Authors
- Wan, Y., Ding, J., Fan, M., & Huang, H.
- Affiliations
- Shandong University of Traditional Chinese Medicine (CN)
- Corresponding author
- Huang, Hailiang
- Venue
- Medicine
- Published
- 2025-07-04
- Volume
- 104
- Issue
- 27
- Pages
- e43107
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC12237333
- OpenAlex
- W4412080525
- Cited by
- 7
- References
- 57
- Citations by year
- 2026: 4 · 2025: 3
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Shandong Traditional Chinese Medicine Famous Expert Liu Zhao-Chun Inheritance Studio (lwzzfz [2018] No. 1)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Light effects on plants
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- seasonal affective disorder, phototherapy, blue light therapy, red light therapy, mood dysregulation, depressive symptoms, usual care
- MeSH terms
- Humans, Light, Phototherapy, Randomized Controlled Trials as Topic, Seasonal Affective Disorder, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis. https://app.cochat.ai/papers/10.1097/md.0000000000043107
- The paper
- Wan, Y., Ding, J., Fan, M., & Huang, H. (2025). Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis. Medicine. https://doi.org/10.1097/md.0000000000043107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.